Source link : https://www.newshealth.biz/health-news/support-for-omitting-slnb-in-some-early-breast-cancers/
SAN ANTONIO — Recent findings from the INSEMA trial provided more evidence that omitting axillary sentinel lymph node biopsy (SLNB) does not compromise survival in women with low-risk, early-stage invasive breast cancer undergoing breast-conserving surgery. Among patients with clinically node-negative, stage T1 or T2 invasive breast cancer, the 5-year invasive disease-free survival (DFS) rate was […]
Author : News Health
Publish date : 2024-12-13 10:06:55
Copyright for syndicated content belongs to the linked Source.